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                        of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and













































How and why we age has long been a fascination of 
humans.  In addition to being of intrinsic philosophical, 
evolutionary and biological interest, determining the 
molecular and cellular mechanisms underlying the 
aging process is relevant to understanding age-related 
pathology that ultimately limits human life and health 
span. Model organism studies have been instrumental in 
understanding  aging,  with many  conserved pathways  
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strains)  extends  yeast  chronological  life  span  (CLS)  by  increasing  mitochondrial  oxygen  consumption,  in  part,  by  up‐




abundance  of  both  mtDNA‐encoded  and  nucleus‐encoded  OXPHOS  subunits  per  mitochondrial  mass.  However,  this
increased OXPHOS complex density is not associated with more mitochondria/cell or cellular ATP and leads to an overall








and factors having been identified in files, worms and 
yeast (and other organisms) that have physiological and 
pathological relevance in humans [1]. One general area 
that has been implicated strongly in aging and life span 
determination is nutrient availability/sensing. For 
example, dietary (i.e. caloric) restriction extends life 
span and ameliorates many of the age-associated 
declines in cellular function in virtually all organisms 
examined to date [2]. 
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availability/sensing is alternation of cellular metabolism 
and mitochondrial respiration. Life span extension by 
caloric restriction, for instance, usually involves 
enhanced mitochondrial activity [2, 3].  While best 
known for providing ATP via oxidative phosphorylation 
(OXPHOS), mitochondria are a major crossroads for 
anabolic and catabolic metabolism, as well as many 
other critical cellular functions such as apoptosis, signal 
transduction, and ion homeostasis [4].  Mitochondria 
also contain a DNA genome (mitochondrial DNA; 
mtDNA) that harbors a set of genes involved in 
OXPHOS and requires dedicated machinery for 
organellar DNA replication and gene expression that is 
encoded primarily by genes in the nucleus (e.g. 
mitochondrial DNA and RNA polymerase, ribosomes, 
transcription and translation factors, etc) [5, 6].     
Mitochondria also generate reactive oxygen species 
(ROS) as byproducts of the electron transport process, 
which is a major way they are thought to contribute to 
the aging process. For example, the “mitochondrial 
theory of aging”, which builds on Harman’s “free-
radical” theory, posits that ROS from mitochondrial 
respiration damage cellular components, including 
mtDNA, and lead to declines in cell, tissue and 
organismal function over time [7, 8].  As ROS are also 
signaling molecules, altered signal transduction is 
another potential contributor to aging phenotypes due to 
mitochondrial dysfunction [9]. While the mechanisms 
through which altered respiration affects life span are 
complex and have not been defined fully, differential 
ROS production is likely involved.  For example, 
aberrant respiration due to defective RAS signaling 
[10], pharmacological inhibition [11], or imbalanced 
translation of mtDNA-encoded OXPHOS subunits [9] 
elevates cellular ROS and severely curtails yeast 
chronological life span (CLS).  Conversely, mild 
uncoupling of mitochondrial respiration extends yeast 
CLS and decreases ROS [11]. 
 
Several kinase pathways serve as physiological switches 
in response to nutrient availability.  For example, the 
conserved target of rapamycin (TOR) signaling pathway 
controls growth by positively regulating the processes 
of ribosome biogenesis and cytoplasmic translation 
when preferred nutrient supplies are available.  In yeast, 
the TOR pathway also negatively regulates stress 
response genes, autophagy, and usage of alternate 
carbon and nitrogen sources [12]. Thus, when nutrients 
are limiting, TOR activity is reduced, energy is 
conserved (by shutting down expensive growth-
promoting pathways) and diverted to provide stress 
resistance and access to alternate energy stores.  The 
TOR kinase forms two multi-protein complexes,  TORC1 
and TORC2, with TORC1 functioning as the nutrient 
sensor [12]. In yeast, there are two TOR kinase genes 
TOR1 and TOR2.  Both Tor1p and Tor2p can function 
in the TORC1 complex, but only Tor2p can function in 
the TORC2 complex.  Thus, deletion of TOR1 results in 
reduced TORC1 signaling, but is not lethal.  This is 
because Tor2p can partially cover the loss of Tor1p in 
TORC1, while still also functioning in TORC2.  In 
contrast, deletion of TOR2 is lethal [13].  Reduced 
TORC1 signaling extends life span in a number of 
model organisms including yeast (S. cerevisiae), worms 
(C. elegans) and flies (D. melanogaster) [14-17].  We 
recently reported that a major mechanism underlying 
this phenotype in yeast is enhanced mitochondrial 
respiration driven, at least in part, by increased 
translation of mtDNA-encoded OXPHOS subunits [18]. 
In that study, we speculated that the extension of CLS 
by reduced TOR signaling involves an increase in the 
number of OXPHOS complexes per organelle that 
increases oxygen consumption, decreases ROS 
production in stationary phase, and thereby limits 
damage to cellular components.  However, since 
mtDNA encodes only minority of the OXPHOS 
complex subunits (i.e. of the ~80 OXPHOS subunits 
only seven in yeast and thirteen in mammals are 
encoded by mtDNA) and mitochondria contain >1,000 
proteins (encoded by nuclear genes and imported into 
the organelle), the possibility that TOR signaling 
regulates mitochondria in a more global fashion is 
likely.  In fact, TOR-dependent changes in the 
mitochondrial proteome have been documented in 
human Jurkat T cells [19]. 
 
Sch9p belongs to the AGC family of kinases and is a 
key downstream target of TORC1 signaling in yeast.   
For example, Sch9p is a functional ortholog of 
ribosomal protein S6 kinase, a key mediator of mTOR 
signaling in mammalian cells [20].  TORC1 directly 
phosphorylates Sch9p at multiple sites, which is 
important for modulating cytoplasmic translation and 
cell cycle progression.  Sch9p is also a negative 
regulator of both chronological and replicative aging 
[14, 21] and has recently been shown to similarly 
regulate mitochondrial respiration [22].  In fact, like 
deletion of TOR1, deletion of SCH9 extends yeast CLS 
in a respiration-dependent fashion, suggesting that 
Sch9p could be a downstream mediator of TOR-
dependent mitochondrial OXPHOS regulation in this 
regard. In the current study, we have examined in 
greater mechanistic detail how the yeast TOR pathway 
influences mitochondrial gene expression, OXPHOS 
activity, and proteome composition, and the role of the 
Sch9p kinase as a downstream mediator of its effects on 
mitochondria. 
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Reduced TOR signaling globally increases 
mitochondrial translation and results in a greater 
number of OXPHOS complexes per organelle 
 
We demonstrated previously that reduced TOR 
signaling (in tor1 null yeast strains; tor1Δ) results in 
increased mitochondrial translation rates, oxygen 
consumption, and life span [18]. This is accompanied 
by a corresponding increase in the steady-state levels of 
mtDNA-encoded OXPHOS subunits. However, whether 
there is global up-regulation of mitochondrial 
translation was not addressed in that study and only a 
single, late culture growth point was analyzed. To better 
understand the mitochondrial translation response to 
reduced TOR signaling, we labeled all mtDNA-encoded 
subunits at three growth points and visualized the 
individual products by autoradiography of SDS-PAGE 
gels. Compared to wild-type strains, we observed global 
up-regulation of mitochondrial translation products in 
log-phase and early stationary phase (day 1) cultures in 
tor1Δ strains (Figure 1). One day later in stationary 
phase (day 2) the wild-type and tor1Δ strains showed 
similar rates of mitochondrial translation, due to an 
increase in the rate in the wild-type strains (Figure 1). 
These results mirrored closely our previously published 
results on oxygen consumption as a function of growth 
state and demonstrate that the major differences in 
mitochondrial function in these strains are manifest 
during growth and early stationary phase, which is 
when TOR signaling is at its highest in wild-type 
strains. 
 
The observed increase in mitochondrial translation in 
tor1Δ strains prompted us to examine additional 
mitochondrial parameters. Here, we focused on mid-log 
growth points, where the largest differences in 
mitochondrial translation and oxygen consumption are 
observed. First, consistent with the increase in 
mitochondrial translation, there was an increase in the 
steady-state levels of mtDNA-encoded OXPHOS 
subunits (3-12 fold) per mitochondrial mass as judged 
by western blotting of Cox1p, Cox2p and Cox3p in 
mitochondrial extracts (Figure 2A). This was 
accompanied by an increase in the Cox4p OXPHOS 
subunit (2.2 fold), but not of porin, both of which are 
encoded by nuclear genes (Figure 2A). This result 
suggested to us that the OXPHOS machinery was up-
regulated more or less specifically and that an overall 
increase in mitochondrial biogenesis was not occurring. 
To test this hypothesis, we transformed the strains with 
a plasmid encoding a mitochondria-targeted GFP 
protein and measured mitochondrial content by FACS, 
as well as determined mtDNA copy number, amounts of 
which usually correlate with mitochondrial abundance. 
No significant differences in mitochondrial mass 
(Figure 2B) or mtDNA (Figure 2C) were observed 
between the wild-type and tor1Δ strains. There also 
were no obvious differences in mitochondrial 
distribution or morphology observed by fluorescence 
microscopy of the GPF-containing strains (data not 
shown). Altogether, these data indicate that there is an 
increase in the number of OXPHOS complexes per 
organelle mass in tor1Δ ￿strains, as opposed to a global 
up-regulation of the amount of mitochondria per cell. 
However, despite the fact there is increased 
mitochondrial OXPHOS components and oxygen 
consumption, there was a reduction in mitochondrial 
membrane potential (Figure 2D) and no significant 
difference in total cellular ATP in tor1Δ ￿strains (data 
not shown). 
 
To better understand how reduced TOR signaling 
dynamically effects respiration, we used the TOR 
kinase inhibitor rapamycin under a variety of 
conditions. Addition of rapamycin to a wild-type culture 
from the beginning of growth resulted in a significant 
and sustained increase in mitochondrial oxygen 
consumption (Figure S1A), similar to that observed in 
tor1Δ strains. However, rapamycin greatly inhibited the 
growth rate of these strains (data not shown). In 
contrast, adding rapamycin at a later point during 
growth (after the strains reached OD ~1.0) only 
increased oxygen consumption by ~30% (Figure S1B). 
This increase required the presence of the drug for 2-4 
hours, was sustained for at least 30 hours (Figure S1B), 
and depended on both cytoplasmic and mitochondrial 
translation (i.e. was inhibited by addition of either 
cycloheximide or chloramphenicol; data not shown). 
 
Reduced TOR signaling increases the steady-state 
levels of mitochondrial transcripts 
 
Given that the overall rates of mitochondrial translation 
were higher in tor1Δ strains, but mtDNA copy number 
was not, led us to investigate the whether there were 
changes in steady-state levels of mitochondrial 
transcripts that might indicate a mtDNA transcriptional 
response. Northern blots of three mitochondrial mRNA 
transcripts revealed that there is a 1.5- to 2.1-fold 
increase in tor1Δ strains (using 25S rRNA as a loading 
control; Figure 3). Similar changes were observed in the 
14S rRNA (data not shown). These data indicate that 
there is a moderate increase in mitochondrial transcripts 
in  tor1Δ strains, but that this is unlikely to be the 
primary driving force behind the significantly greater 
rates of mitochondrial translation and OXPHOS 
complex abundance observed. 
   











   



































































































Western  blot  analysis  of  four  OXPHOS  subunits
(Cox1p‐4p)  and  porin  (as  a  mitochondrial
normalization control).  Fifty μg of mitochondrial
extract  was  loaded  in  each  lane.  The  fold
difference  between  wt  and  tor1Δ  normalized  to




determined  by  real‐time  PCR  (measured  as  the
ratio  of  the  mitochondrial  gene  target  COX1




deviation  are  graphed  (**  represents  a  p‐value
from a student t‐test that is <0.01).
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Global up-regulation of OXPHOS-related proteins 
in tor1Δ mitochondria revealed by 2D-DIGE 
 
 To gain a better understanding of how reduced TOR 
signaling affects mitochondria, we have begun to 
characterize changes in the mitochondrial proteome in 
tor1Δ strains by two-dimensional, differential gel 
electrophoresis (2D-DIGE), coupled to mass spectro-
metry-based identification of differentially regulated 
proteins. Given that we observed an increase in 
OXPHOS subunits/mitochondrial mass by western blot 
(Figure 2A), we have focused initially on those proteins 
that were up-regulated by 2-fold or greater in mito-
chondria from tor1Δ strains (see Materials and 
Methods). Of the 26 up-regulated spots picked and 
analyzed based on this 2-fold cutoff, we have 
unambiguously identified eleven proteins that are at 
higher steady state-levels in mitochondria purified from 
tor1Δ strains in the mid-log growth phase (Table 1). In 
addition to Cox4p, which we had already documented 
as increased by western blot (Figure 2A), we identified 
five other OXPHOS components: Cox13p (another 
subunit of Complex IV), Qcr7 (subunit of Complex III), 
and Atp2p, Atp5p and Atp7p (subunits of Complex 
V/ATP synthase). In addition to OXPHOS components, 
we have thus far identified five other proteins that are 
up-regulated in mitochondria from tor1Δ strains (Table 
1). Three of these (Dld2p, Gcv3p, and Ilv6p) are 



























is an abundant outer mitochondrial membrane protein of 
unknown function, and the final one (Yhb1p) is 
involved in nitric oxide detoxification. Altogether, these 
data solidify our contention that that there is global up-
regulation of OXPHOS machinery/organelle in 
response to reduced TOR signaling, but also indicate 
that TOR activity impacts mitochondrial proteome 
composition in other interesting ways. Furthermore, in 
the case of Gcv1p and Ilv6p, the spots identified of 
wild-type differ in molecular weight and/or PI from 
those of tor1Δ (data not shown), suggesting that TOR 
regulates expression and/or processing of these proteins 
in a unique manner. 
 
 
Balanced expression of mitochondrial OXPHOS 
components is required for extension of chronological 
lifespan mediated by reduced TOR signaling 
 
We previously documented that strains with imbalanced 
expression of mtDNA-encoded OXPHOS subunits have 
reduced chronological life span (CLS) [9]. One strain 
(GS129), in particular, has a severely curtailed CLS due  
to a point mutation in the amino-terminal domain of 
mtRNA polymerase (Rpo41p) that results in increased 
ROS [9]. Given that reduced TOR signaling (due to 
TOR1 deletion) increases CLS, in part by increasing the 
rate of mitochondrial translation [18], we used the 
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TOR1 in the GS129 background resulted in an increase 
in translation of most mtDNA-encoded products to a 
degree that exceeded that in the isogenic wild-type 
strain GS122, but less than that observed in the isogenic 
wild-type  tor1Δ strain (GS122 tor1Δ) (Figure 4A). 
However, unlike in the wild-type strain, there was no 
significant increase in Cox1p translation when TOR1 
was deleted in the GS129 background (Figure 4A). In 
other words, translation was increased in the GS129 
strain in response to reduced TOR signaling, but not in 
a balanced manner. Analysis of CLS in these strains 
revealed that deletion of TOR1 extended life span in the 
wild-type (GS122) background as expected, but did not 
significantly increase CLS in the “imbalanced” GS129 
strain (Figure 4B). These data indicate that extension of 
life span by reduced TOR signaling requires balanced up-





































SCH9 is a downstream target of TOR signaling in 
the regulation of mitochondrial function 
 
Recently, deletion of SCH9 was also shown to increase 
expression of mitochondrial OXPHOS genes and mito-
chondrial respiration [22]. Given that these mitochon-
drial phenotypes are similar to those we have documen-
ted here and previously in tor1Δ strains, we tested the 
hypothesis that SCH9 is downstream of TOR1 with 
regard to mitochondrial regulation by simultaneously 
analyzing isogenic single (tor1Δ or sch9Δ) and double 
(tor1Δ sch9Δ) knock-out strains. As reported previously 
[18], we observed an increase in mitochondrial oxygen 
consumption in the sch9Δ strain that was similar in 
magnitude (2-fold) to the increase observed in the 
isogenic tor1Δ strain (Figure 5A). However, this increase 
was not enhanced further in the tor1Δ sch9Δ double-
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respiration. Similar results were obtained for mito-
chondrial translation rates (Figure 5B) and steady-state 
levels of nucleus and mtDNA-encoded OXPHOS 
proteins (Figure 5C). However, the sch9Δ single mutant 
had a greater effect than the tor1Δ single mutant on 
these latter three parameters, and there was no 
synergistic effect observed in the double-mutant strains 
(Figures 5A and 5B). The fact that the double-mutant 
strain more closely resembled the sch9Δ strain is most 
consistent with SCH9 being downstream of TOR1 in 
this pathway controlling mitochondrial translation and 
respiration. This was evidenced further by the fact that 










































increase in mitochondrial translation that was greater in 
magnitude to that observed in the tor1Δ strain (Figure 
5B). That is, rapamycin or SCH9 deletion appears to 
represent a more complete down-regulation of TOR 
signaling than deletion of TOR1. Finally, comparison of 
the actin and porin ratio (an indicator of mitochondrial 
abundance) in the single and double mutant strains 
(Figure 5C) confirmed that, as was the case for tor1Δ, 
there was no significant increase in overall 
mitochondrial biogenesis in the sch9Δ and tor1Δ sch9Δ 
strains, but rather an increase in the number of 
OXPHOS complexes per organelle mass, again placing 


















































   


























SCH9 is downstream of TOR1 in the regulation of 
chronological life span 
 
We previously implicated reduced ROS in stationary 
phase as a significant factor that increases the CLS of 
tor1Δ strains [18]. A similar reduction in ROS was also 
observed in sch9Δ and tor1Δ sch9Δ strains (Figure 6A), 
again consistent with SCH9 working in the same genetic 
pathway as TOR1 with regard to mitochondria-derived 
ROS. Finally, as was the case for mitochondrial 
translation and OXPHOS complex abundance, we 
found that deletion of SCH9 increased CLS to a greater 
degree than deletion of TOR1, but that there was no 
further increase in CLS in the tor1Δ sch9Δ double 
mutant strain (Figure 6B). Altogether, these data 
solidify the connections between mitochondrial 
OXPHOS, ROS and CLS and demonstrate that Sch9p is 
a key downstream factor that mediates the effects of TOR 
signaling on mitochondrial function and yeast aging. 



































This study provides significant new insight into the 
mechanism through which TOR signaling controls 
mitochondrial function to influence yeast CLS and 
elucidates which arm of the TORC1 pathway is 
involved. The primary conclusions we draw from the 
results obtained are that 1) reduced TORC1 signaling 
(via deletion of the TOR1 gene) increases respiration 
primarily through up-regulation of the number of 
OXPHOS complexes/organelle, not by increasing 
overall mitochondrial biogenesis, 2) the up-regulation 
of OXPHOS complexes involves both mtDNA-encoded 
and nucleus-encoded subunits and, in terms of mtDNA 
expression, occurs primarily via translational regulation, 
3) in addition to its effects on OXPHOS complex 
abundance, TOR signaling controls other aspects of 
mitochondrial proteome dynamics, 4) TOR-dependent 
changes in mitochondrial function and CLS are 
Table 1. Mitochondrial Proteins Identified as Up‐regulated in tor1Δ Yeast Strains by 2D‐DIGE
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TOR-dependent alterations of mitochondrial function in 
the exponential and/or post-diauxic-early stationary 
growth phases that subsequently impact late stationary-
phase survival and extend CLS, which suggests a role of 
“mitochondrial pre-conditioning” on yeast aging. The 
basis of these conclusions and additional interpretations 
are discussed below. 
 
The increase in cellular mitochondrial oxygen 
consumption (i.e. respiration) in response to reduced 
TOR signaling reported herein (Figure 5A) and 
previously [18] could occur by one of several 
mechanisms that are not mutually exclusive. For 
example, it could be mediated by direct effects on the 
activity of existing OXPHOS complexes, by increasing 
overall mitochondrial biogenesis (resulting in more 
mitochondria/cell), or by increasing the number of 
OXPHOS complexes per organelle. Our results 
demonstrate that increasing organelle OXPHOS 



































The basis for this conclusion is that, in mitochondrial 
extracts, we observe increased abundance of both 
nuclear and mitochondrial OXPHOS subunits, but not 
other mitochondrial markers (e.g. porin; Figure 2A). 
This result was substantiated by our initial 2D-DIGE 
proteomic analysis of highly purified mitochondria from 
wild-type and tor1Δ strains, in which we identified 
OXPHOS complex subunits (from three separate 
complexes) as proteins that are in significantly higher 
abundance in mitochondria from tor1Δ cells (Table 1). 
Finally, there was no increase in overall mitochondrial 
biogenesis as judged by mtDNA content (Figure 2C), 
labeling of mitochondria with a GFP marker and 
analyzing them by FACS (Figure 2B), and western blot 
comparisons of mitochondrial and cytoplasmic markers 
(Figure 5C). While increased OXPHOS complex 
density is clearly occurring, we have not eliminated the 
possibility that there are also TOR-dependent effects on 
the enzymatic activity of the complexes that contribute 
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recent proteomic study of rapamycin-treated yeast cell 
[23], where fewer OXPHOS proteins were identified as 
up-regulated. We found that addition of rapamycin 
during the growth phase impacts mitochondrial oxygen 
consumption on a longer time scale and to a lesser 
degree compared to adding rapamycin from the 
beginning of the growth experiment (i.e. at inoculation; 
Supplemental Figure S1). The latter condition is in 
some ways more similar to the tor1Δ strains analyzed in 
this study in that, in this case, TOR signaling is reduced 
throughout all stages of growth. Thus, differences in the 
timing and/or degree of TOR inhibition may explain the 
different results obtained in the two studies. 
 
To increase OXPHOS complex density as a means to 
increase mitochondrial oxygen consumption is to our 
knowledge a unique mechanism of mitochondrial 
regulation levied by the TOR pathway. We originally 
hypothesized that this would lead to greater 
mitochondrial membrane potential due to the increase in 
electron transport activity and perhaps also a higher 
cellular ATP. However, this was not the case; there was 
instead a decrease in membrane potential in tor1Δ 
strains (Figure 2D) and no change in cellular ATP (data 
not shown). Thus, in tor1Δ strains, there in an increase 
in electron transport activity (i.e. oxygen consumption) 
and a decrease in mitochondrial membrane potential, 
which equates to a mitochondrial network with overall 
lower energy capacity on average. One potential 
explanation for this result is that reduced TOR signaling 
is leading to an increase in uncoupled respiration. This 
would lead to increased oxygen consumption in an 
attempt to maintain the membrane potential in the face 
of the proton leak and an inability to simultaneously 
increase ATP production. Since mild uncoupling also 
increases CLS [11], this indeed may prove to be the 
mechanism through which TOR signaling influences 
aging in yeast. Testing this hypothesis is a logical area 
of future investigation, but certainly other explanations 
can be envisioned. 
 
In order to affect an increase in OXPHOS complexes 
per mitochondrion, the cell needs to increase the 
production and/or stability of both mtDNA-encoded and 
nucleus-encoded OXPHOS subunits, while not inducing 
a full mitochondrial biogenesis response. How reduced 
TOR signaling accomplishes this remains to be 
determined, yet several insights are gleaned from our 
results. First, we observe an increase in both mtDNA-
encoded and nucleus-encoded OXPHOS subunits 
(Figure 2A, Table 1), thus TOR signaling is affecting 
both mitochondrial and nuclear gene expression 
simultaneously. According to our results, this is 
occurring both at the mRNA level (Figure 3) and at the 
translational level (Figure 1) in mitochondria, but not at 
the level of protein stability to any obvious degree 
(Figure 5B, Supplemental Figure S2). Since transcript-
tion and translation are coupled in mitochondria [24-
26], these changes probably work together to mediate 
the increase in OXPHOS complex abundance in tor1Δ 
strains. Although, the translational control appears to 
contribute to a greater extent, given only modest 
changes in mitochondrial transcript levels are observed. 
However, the change in mitochondrial transcripts of 
tor1Δ strains might represent a reduction of glucose 
repression, which is known to induce mitochondrial 
transcription [27, 28] and mimic the effects of tor1Δ on 
respiration and CLS based on our previous study [18]. 
Interesting in this regard is the key role of the Snf1p 
kinase in the glucose repression phenomenon [29]. 
Snf1p is the yeast ortholog of mammalian AMP kinase, 
which negatively regulates mTOR signaling in response 
to energy charge by activating Tsc2, an inhibitor of 
mTORC1 [30]. Though a Tsc2 ortholog appears to be 
absent in yeast, these correlations might suggest an 
evolutionarily conserved regulatory framework that 
links glucose metabolism, TOR signaling, 
mitochondrial gene expression and life span. 
 
Whether the increase in nuclear OXPHOS gene 
expression is mediated at the transcriptional or post-
transcriptional level remains to be determined, as does 
the identity of the putative TOR-regulated 
mitochondrial factors that meditate the increase in 
mitochondrial mRNA transcription/stability and 
translation of mtDNA-encoded OXPHOS subunits. 
Certainly, nuclear transcription factors that are known 
to be downstream of TORC1 [31], involved in nuclear-
mitochondrial signaling [32], or in glucose repression of 
mitochondrial function [33] are obvious candidates to 
test with regard to the nuclear gene expression response. 
And, with regard to TOR-dependent factors that 
regulate mitochondrial gene expression directly, the 
mitochondrial transcription machinery, mitochondrial 
ribosomes, or the various general and specific 
translational activators [5] are likely candidates to 
consider in future studies. Furthermore, since our results 
clearly implicate Sch9p as the key mediator of the 
TORC1-mitochondria-CLS pathway (Figure 6B), 
searching for mitochondrial substrates of Sch9p as 
potential downstream targets that execute changes in 
mitochondrial gene expression and OXPHOS activity 
would likely be fruitful. 
 
The fact that up-regulation of mitochondrial oxygen 
consumption [18] and mitochondrial translation (Figure 
1) in tor1Δ strains occurs only in log-phase and early 
stationary phase cultures (and not later in stationary 
phase) strongly suggests that TOR-dependent 
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for the life span extension later in stationary phase. The 
concept of early mitochondrial-related events effecting 
life span has been promoted by others in aging studies 
in C. elegans [34, 35] and is also consistent with the 
observation of Piper and colleagues that previous 
conditioning of yeast to respiratory conditions extends 
CLS in subsequent cultures [36]. While, at this point, 
the molecular explanation for this “mitochondrial pre-
conditioning” effect is not clear, we consider ROS 
signaling as one potential model. This idea is attractive 
because the rate of production of ROS from the 
mitochondrial electron transport chain is likely an 
accurate reflection of mitochondrial OXPHOS activity 
and/or redox status that could be used by cells as a 
retrograde signal to modulate nutrient-sensing 
pathways. Although we have not observed a significant 
change in the steady-state level of superoxide in log-
phase tor1Δ cells (data not shown), it is possible that 
other ROS species may be relevant or that the steady-
state measurements are not accurately predicting the 
rate of mitochondrial ROS production. Alternatively, 
we observed up-regulation of Yhb1, a nitric oxide 
detoxifying enzyme in tor1Δ mitochondria, but not 
Sod2p (data not shown; [18]). These results might 
suggest a role for NO and/or other reactive nitrogen 
species as relevant. Interesting in this regard, as is the 
case in tor1Δ cells (Table 1), Yhb1p localizes to 
mitochondria under anaerobic condition [37]. This, 
coupled to our observation that hypoxic conditions 
bypass the extension of CLS by TOR1 deletion [18] 
might suggest that reduced TOR signaling and 
anaerobic conditions share a common route to impact 
life span that may involve NO metabolism. Future 
studies along these and related lines, as well as further 
characterization of TOR-dependent changes in the 
mitochondrial proteome should be most revealing in 
terms of understanding how the TOR-mitochondria axis 
controls aging and deciphering the complex 
relationships between OXPHOS activity, ROS (and/or 
other reactive species), nutrient sensing, and life span. 
This, in turn, may provide new inroads into 
understanding and perhaps counteracting age-related 
pathology in humans. 
 
MATERIALS AND METHODS 
 
Yeast strains.  Unless otherwise stated, strains of the 
DBY2006 (MATa his3-Δ200 leu2-3,-112 ura3-52 trp1- 
Δ1 ade2-1) background were used exclusively. The 
GS122 and GS129 strains are derivatives of DBY2006 
that have plasmid-borne RPO41 and rpo41-R129D 
alleles covering a chromosomal disruption of the 
endogenous  RPO41 gene and have been described 
previously [24]. These strains were used for the 
experiments presented in Figures 1 and 4. The TOR1 
gene was disrupted in these strains as described 
previously [18]. The SCH9 gene was disrupted using a 
standard HIS3 knockout cassette [38]. Briefly, the HIS3 
in pRS313 was PCR amplified with primers 
ACCACCGCTATTAGTCAGGACTTATATGCAATG
GGCACAACAGGAATAACAAGATTGTACTGAGA
GTGCAC (SCH9_LeftDel) and CATCATTGATGTCC 
TCGTCCCCGTCATCATCGATGACATCTTCGTCTG 
GACTGTGCGGTATTTCACACCG (SCH9_RightDel).  
Gel-purified amplicons were used to transform wild-
type and tor1Δ DBY2006. His+ transformants were 
selected on his- plates and single colonies were picked 
and verified by PCR. The mitochondrial GFP 
expressing yeast strains were generated by transforming 
wild-type DBY2006 and tor1Δ with pYX142-SU9-GFP 
[39]. 
 
Mitochondria purification. Mitochondria were isolated 
from yeast (from cultures grown to OD600=1.0 in 
selective media) by differential centrifugation followed 
by sucrose-gradient fractionation as described [40]. For 
2D-DIGE, the purity of mitochondrial preparations was 
checked by western blot analysis with anti-actin 
(Chemicon, 1:1000), anti-alkaline phosphatase 
(Molecular Probe 1:1000), anti-Dol-P-Man synthase 
(Molecular Probes, 1:1000) antibodies to control for 
contamination of cytoplasm, vacuolar membrane, and 
ER membrane respectively. Only residual ER 
contamination was present in the purified mitochondrial 
preparations (data not shown). 
 
Mitochondrial translation assay.  Unless otherwise 
stated, mitochondrial translation assays were performed 
as described [25], except the following: all reactions 
were carried out at 30
0C, gradient gels (6-20%, Figures 
1 and 4; 15-22.5%, Figure 5) were used to resolve 
translation products and electrophoresis was conducted 
at a constant current of 30 mA.  
 
Chronological Life Span Assay. Chronological life span 
was assayed as described previously [9, 18] Unless 
otherwise stated, viability was determined by staining 
with 0.4% trypan blue. 
  
Measurement of mtDNA Copy Number. The mtDNA 
copy number was determined using a quantitative real-
time PCR procedure as described previously [41, 42].  
 
Northern Analysis.  Northern blots were performed as 
described previously [24, 42]. Briefly, 5 μg of total 
RNA extracted from yeast (cultured to an OD600=1) was 
separated on a 1.5% agarose-formaldehyde gel and then 
transferred to a nylon membrane by capillary action. 
Radiolabeled probes were synthesized by PCR with 
32P-
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(GE Healthcare) and incubated overnight at 42 
0C. The 
membrane was washed at room temperature with 
increasing stringency before visualization by auto-
radiography as described in the references cited above.  
 
Western Blot Analysis. Western blots of mitochondria 
and total cell extracts (from cultures at (OD600=1) was 
performed as described previously [18, 25]. Proteins 
were separated on a 10% SDS-PAGE, transferred to a 
PVDF membrane, and incubated with the indicated 
primary and HRP-conjugated anti-mouse secondary 
(Molecular Probes) antibodies as described previously 
[18, 25]. Anti-Cox4p (MitoSciences) antibody (not used 
previously) was diluted 1:1000 for incubation with the 
blocked membrane. 
 
2D-DIGE.  Mitochondrial extraction followed steps 
mentioned in the “mitochondrial extraction” section. 2D-
DIGE was conducted by the W.M. Keck Facility of Yale 
University (http://keck.med.yale.edu/dige/). Briefly, 
protein samples were prepared by TCA-precipitation of 
mitochondrial extracts from DBY2006 and tor1Δ. The 
samples were further cleaned with 2-D Clean-Up Kit (GE 
Healthcare) and labeled with CyDye DIGE fluors 
(Amersham). 50 μg of the labeled samples were resolved 
on a 2D gel (Ettan DIGE system from Amersham). A 
representative 2D gel and the distribution of up-regulated 
and down-regulated proteins is shown in Supplemental 
Figure S3. In this study, 26 proteins that were up-
regulated by 2-fold or more were selected for MALDI-
MS/MS analysis. We were able to unambiguously 
identify 11 of these based on multiple peptide matches.   
 
Flow Cytometry.  All analysis was performed on a 
Beckton-Dickenson  FACSCalibur.  Analysis of yeast 
ROS using DHE was performed as described previously 
[9]. For measurement of mitochondrial potential, cells 
from a growing culture were pelleted by centrifugation 
and washed with phosphate-buffered saline (PBS). 
DiOC6  (Molecular Probes) was diluted to a final 
concentration of 200 nM in PBS and used to resuspend 
the cells. The cell suspension was then incubated for 30 
minutes at 30 
0C, washed twice with PBS, and analyzed 
by flow cytometry using the FL3 channel without 
compensation. For measurement of mitochondrial mass, 
cultured GFP expressing yeast cells were pelleted, 
washed once and then re-suspended in PBS, and subject 
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Supplement  Figure  2.  Newly  synthesized  mtDNA‐
encoded OXPHOS subunits have similar stability in
wild‐type and tor1Δ strains. The experiment shown is
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